Protein misfolding and obstructive lung disease

Proceedings of the American Thoracic Society

Volumn 7, Issue 6, 2010, Pages 346-355

  Greene, Catherine M ^a   McElvaney, Noel G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

A1 antichymotrypsin; A1 antitrypsin; Endoplasmic reticulum stress

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; METABOLISM; PROTEIN FOLDING; PROTEOSTASIS DEFICIENCY; REVIEW;

HUMANS; LUNG DISEASES, OBSTRUCTIVE; PROTEIN FOLDING; PROTEOSTASIS DEFICIENCIES;

EID: 79952638021     PISSN: 15463222     EISSN: 19435665     Source Type: Journal    
DOI: 10.1513/pats.201002-019AW     Document Type: Conference Paper

References (57)

1. Malhotra JD, Kaufman RJ. The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol 2007;18:716-731.
2. Perlmutter DH. Liver injury in a1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury. J Clin Invest 2002;110:1579-1583.
3. Teckman JH, Perlmutter DH. Retention of mutant a1-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response. Am J Physiol Gastrointest Liver Physiol 2000;279:G961-G974.
4. Teckman JH, An JK, Loethen S, Perlmutter DH. Fasting in a1-antitrypsin deficient liver: constitutive activation of autophagy. Am J Physiol Gastrointest Liver Physiol 2002;283:G1156-G1165.
5. Teckman JH, An JK, Blomenkamp K, Schmidt B, Perlmutter D. Mitochondrial autophagy and injury in the liver in a1-antitrypsin deficiency. Am J Physiol Gastrointest Liver Physiol 2004;286:G851-G862.
6. Mason DY, Cramer EM,Masse JM, Crystal R, Bassot JM, Breton-Gorius J. a1-Antitrypsin is present within the primary granules of human polymorphonuclear leukocytes. Am J Pathol 1991;139:623-628.
7. Travis J, Shieh BH, Potempa J. The functional role of acute phase plasma proteinase inhibitors. Tokai J Exp Clin Med 1988;13:313-320.
8. Greene CM, Miller SD, Carroll TP, Oglesby IK, Ahmed F, O'Mahony M, Taggart CC, McElvaney NG, O'Neill SJ. Anti-apoptotic effects of Z a1-antitrypsin in human bronchial epithelial cells. Eur Respir J 2010;35:1155-1163.
9. Lomas DA, Mahadeva R. Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 2002;110:1585-1590.
10. McCracken AA, Kruse KB, Brown JL. Molecular basis for defective secretion of the Z variant of human a1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342. Mol Cell Biol 1989;9:1406-1414.
11. Lomas DA, Evans DL, Finch JT, Carrell RW. The mechanism of Z a1-antitrypsin accumulation in the liver. Nature 1992;357:605-607.
12. Taggart C, Cervantes-Laurean D, Kim G, McElvaney NG, Wehr N, Moss J, Levine RL. Oxidation of either methionine 351 or methionine 358 in a1-antitrypsin causes loss of anti-neutrophil elastase activity. J Biol Chem 2000;275:27258-27265.
13. Carrell RW, Whisstock J, Lomas DA. Conformational changes in serpins and the mechanism of a1-antitrypsin deficiency. Am J Respir Crit Care Med 1994;150:S171-S175.
14. Poller W, Faber JP, Weidinger S, Tief K, Scholz S, Fischer M, Olek K, Kirchgesser M, Heidtmann HH. A leucine-to-proline substitution causes a defective a1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics 1993;17:740-743.
15. Gooptu B, Hazes B, Chang WS, Dafforn TR, Carrell RW, Read RJ, Lomas DA. Inactive conformation of the serpin a1-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease. Proc Natl Acad Sci USA 2000;97:67-72.
16. Lawless MW, Greene CM, Mulgrew A, Taggart CC, O'Neill SJ, McElvaney NG. Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z a1-antitrypsin deficiency. J Immunol 2004;172:5722-5726.
17. Szegezdi E, Logue SE, Gorman AM, Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006;7:880-885.
18. Greene CM, Miller SD, Carroll T, McLean C, O'Mahony M, Lawless MW, O'Neill SJ, Taggart CC, McElvaney NG. a1-Antitrypsin deficiency: a conformational disease associated with lung and liver manifestations. J Inherit Metab Dis 2008;31:21-34.
19. Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 2004;36:1199-1207.
20. Malhotra D, Thimmulappa R, Vij N, Navas-Acien A, Sussan T, Merali S, Zhang L, Kelsen SG, Myers A, Wise R, et al. Heightened endoplasmic reticulum stress in the lungs of patients with chronic obstructive pulmonary disease: the role of Nrf2-regulated proteasomal activity. Am J Respir Crit Care Med 2009;180:1196-1207.
21. Carroll T, Greene CM, O'Connor CA, Nolan A, O'Neill SJ, McElvaney NG. Evidence for unfolded protein response activation in monocytes from individuals with a1-antitrypsin deficiency. J Immunol 2010;184: 4538-4546.
22. Hitomi J, Katayama T, Eguchi Y, Kudo T, Taniguchi M, Koyama Y, Manabe T, Yamagishi S, Bando Y, Imaizumi K, et al. Involvement of caspase-4 in endoplasmic reticulum stress-induced apoptosis and b-induced cell death. J Cell Biol 2004;165:347-356.
23. Elyaman W, Terro F, Suen KC, Yardin C, Chang RC, Hugon J. BAD and Bcl-2 regulation are early events linking neuronal endoplasmic reticulum stress to mitochondria-mediated apoptosis. Brain Res Mol Brain Res 2002;109:233-238.
24. Yoneda T, Imaizumi K, Oono K, Yui D, Gomi F, Katayama T, Tohyama M. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem 2001; 276:13935-13940.
25. Miller SD, Greene CM, McLean C, Lawless MW, Taggart CC, O'Neill SJ, McElvaney NG. Tauroursodeoxycholic acid inhibits apoptosis induced by Z a1-antitrypsin via inhibition of bad. Hepatology 2007;46:496-503.
26. Petrache I, Fijalkowska I, Medler TR, Skirball J, Cruz P, Zhen L, Petrache HI, Flotte TR, Tuder RM. Alpha-1 antitrypsin inhibits caspase-3 activity, preventing lung endothelial cell apoptosis. Am J Pathol 2006;169:1155-1166.
27. Aldonyte R, Hutchinson TE, Jin B, Brantly M, Block E, Patel J, Zhang J. Endothelial a1-antitrypsin attenuates cigarette smoke induced apoptosis in vitro. COPD 2008;5:153-162.
28. Hamanaka RB, Bobrovnikova-Marjon E, Ji X, Liebhaber SA, Diehl JA. Perk-dependent regulation of iap translation during ER stress. Oncogene 2009;28:910-920.
29. Varfolomeev E, Goncharov T, Fedorova AV, Dynek JN, Zobel K, Deshayes K, Fairbrother WJ, Vucic D. C-iap1 and c-iap2 are critical mediators of tumor necrosis factor alpha (TNFa)-induced NF-kB activation. J Biol Chem 2008;283:24295-24299.
30. Rothe M, Pan MG, Henzel WJ, Ayres TM, Goeddel DV. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995;83:1243-1252.
31. Shi Y, Vattem KM, Sood R, An J, Liang J, Stramm L, Wek RC. Identification and characterization of pancreatic eukaryotic initiation factor 2 alpha-subunit kinase, PEK, involved in translational control. Mol Cell Biol 1998;18:7499-7509.
32. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, Zobel K, Dynek JN, Elliott LO, Wallweber HJ, et al. Iap antagonists induce autoubiquitination of c-IAPs, NF-kB activation, and TNFa-dependent apoptosis. Cell 2007;131:669-681.
33. Elliott PR, Bilton D, Lomas DA. Lung polymers in Za1-antitrypsin deficiency-related emphysema. Am J Respir Cell Mol Biol 1998;18: 670-674.
34. Mulgrew AT, Taggart CC, LawlessMW, Greene CM, Brantly ML, O'Neill SJ, McElvaney NG. Z a1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant. Chest 2004;125:1952-1957.
35. Mahadeva R, Atkinson C, Li Z, Stewart S, Janciauskiene S, Kelley DG, Parmar J, Pitman R, Shapiro SD, Lomas DA. Polymers of Z a1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol 2005;166:377-386.
36. McLean C, Greene CM, McElvaney NG. Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency. Biologics 2009;3: 63-75.
37. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. Functional anatomy of siRNAs for mediating efficient RNai in Drosophila melanogaster embryo lysate. EMBO J 2001;20:6877-6888.
38. McLean C. Gene targeted inhibition in a1-antitrypsin deficiency. PhD. thesis. Dublin: Royal College of Surgeons in Ireland; 2009. p. 157.
39. Cruz PE, Mueller C, Cossette TL, Golant A, Tang Q, Beattie SG, Brantly M, Campbell-Thompson M, Blomenkamp KS, Teckman JH, et al. In vivo post-transcriptional gene silencing of a1-antitrypsin by adeno-associated virus vectors expressing siRNA. Lab Invest 2007;87: 893-902.
40. Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, Albuquerque RJ, Yamasaki S, Itaya M, Pan Y, et al. Sequence-and target-independent angiogenesis suppression by siRNA via TLR3. Nature 2008;452:591-597.
41. Nielsen PE, Egholm M, Berg RH, Buchardt O. Sequence-selective recognition of DNA by strand displacement with a thyminesubstituted polyamide. Science 1991;254:1497-1500.
42. Kruger K, Grabowski PJ, Zaug AJ, Sands J, Gottschling DE, Cech TR. Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena. Cell 1982;31:147-157.
43. Ozaki I, Zern MA, Liu S, Wei DL, Pomerantz RJ, Duan L. Ribozymemediated specific gene replacement of the a1-antitrypsin gene in human hepatoma cells. J Hepatol 1999;31:53-60.
44. Devlin GL, Parfrey H, Tew DJ, Lomas DA, Bottomley SP. Prevention of polymerization of M and Z a1-antitrypsin (a1-AT) with trimethylamine n-oxide: implications for the treatment of a1-at deficiency. Am J Respir Cell Mol Biol 2001;24:727-732.
45. Sharp LK, Mallya M, Kinghorn KJ, Wang Z, Crowther DC, Huntington JA, Belorgey D, Lomas DA. Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis. FEBS J 2006;273:2540-2552.
46. Burrows JA, Willis LK, Perlmutter DH. Chemical chaperones mediate increased secretion of mutant a1-antitrypsin (a1-at) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in a1-at deficiency. Proc Natl Acad Sci USA 2000;97:1796-1801.
47. Marcus NY, Perlmutter DH. Glucosidase and mannosidase inhibitors mediate increased secretion of mutant alpha1 antitrypsin Z. J Biol Chem 2000;275:1987-1992.
48. Mahadeva R, Dafforn TR, Carrell RW, Lomas DA. 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization: implications for the prevention of Z a1-antitrypsinrelated cirrhosis. J Biol Chem 2002;277:6771-6774.
49. Parfrey H, Dafforn TR, Belorgey D, Lomas DA, Mahadeva R. Inhibiting polymerization: new therapeutic strategies for Z a1-antitrypsinrelated emphysema. Am J Respir Cell Mol Biol 2004;31:133-139.
50. Parfrey H, Mahadeva R, Ravenhill NA, Zhou A, Dafforn TR, Foreman RC, Lomas DA. Targeting a surface cavity of a1-antitrypsin to prevent conformational disease. J Biol Chem 2003;278:33060-33066.
51. Chang YP, Mahadeva R, Chang WS, Shukla A, Dafforn TR, Chu YH. Identification of a 4-mer peptide inhibitor that effectively blocks the polymerization of pathogenic Z a1-antitrypsin. Am J Respir Cell Mol Biol 2006;35:540-548.
52. Chang YP, Mahadeva R, Chang WS, Lin SC, Chu YH. Small-molecule peptides inhibit Z a1-antitrypsin polymerization. J Cell Mol Med 2008;13:2304-2316.
53. Kelly E, Greene CM, Carroll TP, McElvaney NG, O'Neill SJ. Selenoprotein S/SEPS1 modifies endoplasmic reticulum stress in Z variant a1-antitrypsin deficiency. J Biol Chem 2009;284:16891-16897.
54. Vunta H, Davis F, Palempalli UD, Bhat D, Arner RJ, Thompson JT, Peterson DG, Reddy CC, Prabhu KS. The anti-inflammatory effects of selenium are mediated through 15-deoxy-d12,14-prostaglandin J2 in macrophages. J Biol Chem 2007;282:17964-17973.
55. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN. Characterization of mammalian selenoproteomes. Science 2003;300:1439-1443.
56. Rayman MP. Selenium in cancer prevention: a review of the evidence and mechanism of action. Proc Nutr Soc 2005;64:527-542.
57. See KA, Lavercombe PS, Dillon J, Ginsberg R. Accidental death from acute selenium poisoning. Med J Aust 2006;185:388-389.